2016
DOI: 10.1002/bies.201500118
|View full text |Cite
|
Sign up to set email alerts
|

RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives

Abstract: Regulators of G protein signalling (RGS) proteins provide timely termination of G protein-coupled receptor (GPCR) responses. Serving as a central control point in GPCR signalling cascades, RGS proteins are promising targets for drug development. In this review we discuss the involvement of RGS proteins in the pathophysiology of the gastrointestinal inflammation and their potential to become a target for anti-inflammatory drugs. Specifically, we evaluate the emerging evidence for modulation of selected receptor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 93 publications
0
18
0
Order By: Relevance
“…Interestingly, oxidative stress conditions increase RGS2 mRNA levels [79,80]; moreover, RGS2 contributes to the regulation of some enzymes involved in antioxidant defense, namely glyoxalase-1 and glutathione reductase-1 [81]. Finally, RGS2 has been shown to be involved in the pathophysiology of gastrointestinal inflammation and visceral pain, mostly regulating T-cell immunity [79,82,83]. In our opinion, the observed RGS2 gene downregulation can be viewed as the consequence of an indirect positive effect of GP on the overall cattle gastrointestinal tract homeostasis.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, oxidative stress conditions increase RGS2 mRNA levels [79,80]; moreover, RGS2 contributes to the regulation of some enzymes involved in antioxidant defense, namely glyoxalase-1 and glutathione reductase-1 [81]. Finally, RGS2 has been shown to be involved in the pathophysiology of gastrointestinal inflammation and visceral pain, mostly regulating T-cell immunity [79,82,83]. In our opinion, the observed RGS2 gene downregulation can be viewed as the consequence of an indirect positive effect of GP on the overall cattle gastrointestinal tract homeostasis.…”
Section: Discussionmentioning
confidence: 99%
“…For example, upregulation of miR-29a in the blood exosomes of IBS patients is involved in the regulation of intestinal permeability [15]. Regulators of G protein signaling (RGS) proteins play a role in gastrointestinal inflammation and visceral pain by regulating the G protein-coupled receptors (GPCRs) in the gastrointestinal tract, thereby modulating the activity of endogenous opioid, cannabinoid, and serotonin systems [16]. Moreover, a recent study reports that mesenchymal stem cell-derived exosomal miR-148b-5p mediates the immunosuppressive effect through downregulating 15-LOX-1 in macrophages in inflammatory bowel disease [17].…”
Section: Introductionmentioning
confidence: 99%
“…RGS proteins act as GTPase-activating proteins (GAPs) by interacting directly with activated Gα and accelerating GTP hydrolysis thereby promoting G-protein inactivation upon reassembly of the inactive Gαβγ heterotrimer. The action of the RGS proteins is essential in providing control over both the extent and duration of signaling (Hollinger and Hepler, 2002; Ross and Wilkie, 2000) and deficits in this control results in severe dysregulation of GPCR signaling causing a number of human pathophysiological conditions (Woodard et al, 2015; Salaga et al, 2016; Druey, 2017; Sjögren, 2017).…”
Section: Introductionmentioning
confidence: 99%